Nodular Calcium & Ivl: 8 JUNE 2023 Bhojraj Tiwari
Nodular Calcium & Ivl: 8 JUNE 2023 Bhojraj Tiwari
Nodular Calcium & Ivl: 8 JUNE 2023 Bhojraj Tiwari
4
5
Impact of Coronary Calcium
Leads to Stent Under-expansion
1. Mintz, G; I. J Am Coll Cardiol Imaging 2015;8(4): 461-71. 2. Généreux P, et al. JACC 2014; 63(18);1845-54
Designed in Partnership with Optima Education Ltd & VP Education
IVUS demonstrating
circumferential calcification
Combined Endpoint:
MI & Death 22.9% 10.9% <0.001
MI, Death & 31.8% 22.4% <0.001
Revascularization
*Severe Calcium: radiopacities noted without cardiac motion before contrast, generally compromising both sides of arterial lumen
Bourantas, et al. Prognostic implications of coronary calcification in patients with obstructive coronary artery disease treated by percutaneous coronary intervention: a patient-
level pooled analysis of 7 contemporary stent trials. BMJ 2014; 100: 1158-1164.
• Kidney disease,
• Diabetes,
• Bad cholesterol ,
• High BMI,
• Family history of coronary artery calcification,
• Blood pressure,
• Cigarette smoking or using tobacco products,
• Older age,
• Parathyroid hormone irregularities,
• High phosphate levels,
• High calcium level.
• After age 40, calcium from your bloodstream can settle in parts of your body.
• Damaged, inflamed or repaired arteries are more likely to attract calcium deposits
• Ca2+ gets concentrated due to membrane damage .
• Ca+ ion binds to phospholipids present in Membrane .
• Phosphatase generates phosphate group. This Ca & Phosphate binding cycle
is repeated , generating a micro-crystal, which propagate more calcium
deposit
Concentric Ca2+ Eccentric Ca2+ Nodular Ca2+ Very Thick Concentric Ca2+ Uncrossable Ca2+
– SCD without previous histories of coronary heart disease had acute thrombosis in more
than 50% of cases
– The most common causes of acute coronary thrombosis are plaque rupture (65%),
followed by plaque erosion (30%),
– For plaque rupture, a disruption of the thin fibrous cap overlying a necrotic core is
considered the trigger for thrombus formation
– Whereas in plaque erosion, there is an acute luminal thrombus in direct contact with
the intima, which exhibits an absence of endothelial cells
– Necrotic Core: Clinically vulnerable plaque , a structure of which contains dead cells
that have undergone a type of cell death known as necrosis
– Fibrous Plaque: thickening of wall of artery as a result of accumulation of smooth
muscle cell and fibrous tissue in the Intima
18
Lets Start learning about Nodular Calcium
19
Calcified Nodules: What do we Know?
1) Mori H, et al. JACC Cardiovasc Imaging. 2018 Jan;11(1):127-142. 2) Torii S, et al. J Am Coll Cardiol. 2021 Apr 6;77(13):1599-1611. 3)Virmani R, et al. Arterioscler
Thrombosis Vasc Biol 2000;20:1262-1275. Designed in Partnership with Optima and VP Education.
Eruptive Nodular: small dense fragments or nodules of Non-Eruptive Nodular: small dense fragments or
calcium with fibrous cap disruption and luminal thrombus. nodules of calcium with smooth intact fibrous cap.
Proximal to
mid LAD
Proximal to
mid RCA
Proximal LCx
1) Virmani R, et al. Arterioscler Thrombosis Vasc Biol 2000;20:1262-1275. 2) Mori H, et al. JACC Cardiovasc Imaging. 2018 Jan;11(1):127-142. 3) Torii S, et al. J Am Coll
Cardiol. 2021 Apr 6;77(13):1599-1611.
– For SCD, the least frequent cause is calcified nodule (CN) (5%)
– CN as “a lesion with fibrous cap disruption and luminal thrombus associated with
eruptive, dense, calcific nodules” or an occlusive or nonocclusive platelet/fibrin thrombus
– Evidence of fibrous cap disruption is absent in nodular calcification, whereas, in CN, a
disruption of the fibrous cap is observed with an absence of endothelium, and there is an
overlying platelet/fibrin thrombus.
– Calcification without evidence of collagen can occur within an area of a NC and is thus
called NC calcification, and when calcification involves collagen, it is called collagen (C)
calcification
– More than 60% of Culprit lesions of CN were located in the right coronary artery (RCA)
with many of those located in the middle and the others located in the proximal region of
the artery.
– lesions were located in the bifurcation of the left main trunk (LMT)
Atherectomy Therapies
Burr Susceptible
to Wire Bias
1 Madhavan MV, Tarigopula M, Mintz GS, Maehara A, Stone GW, Généreux P. Coronary artery calcification: pathogenesis and prognostic implications. J Am Coll Cardiol 2014;63:1703.
Designed in Partnership with Optima Education Ltd & VP Education
Circumferential modification
of calcium from superficial
to deep
Fracture
30
Clinical impact of calcified nodule in patients with heavily calcified
lesions requiring rotational atherectomy: CCI Jan-2021
Toru Morofuji 1, Shoichi Kuramitsu 1, Tomohiro Shinozaki 2, Hiroyuki Jinnouchi 1, Shinjo Sonoda 3,
• Objectives: To evaluate the incidence and clinical impact of calcified nodule (CN) in patients with heavily
calcified lesions requiring rotational atherectomy (RA).
• Background: It remains unclear whether CN impacts adversely on clinical outcomes in patients with heavily
calcified lesions
• Methods: Between January 2011 and February 2014, 264 patients after second-generation drug-eluting stent
(DES) implantation following RA were retrospectively enrolled. The primary endpoint was the cumulative 5-year
incidence of major adverse cardiac events (MACE), defined as a composite of cardiac death, clinically driven
target lesion revascularization (CDTLR), and definite stent thrombosis (ST).
• Results:
• CN was observed in 128 patients (48.5%) with heavily calcified lesions.
• Cumulative 5-year incidence of MACE was significantly higher in the CN group than in the non-CN group
(35.4% vs. 18.8%, , p < .001)
• Higher rate of CDTLR 23.2% in CN group vs. 7.9% in Non-CN group
• Higher rate of ST 7.0% CN vs. 0.93% Non-CN .
• Independent risk factors of 5-year MACE included haemodialysis, ostial lesion, left ventricular ejection fraction
and right coronary artery lesion .
31 • Conclusions: CN PCI resulting in unfavourable long-term clinical outcomes after RA.
Nodules Treated with RA Result in Worse Long-Term Outcomes
• Objectives: To study characteristics and pattern of a CN and/or NC IVUS on the DoCE in patients with
calcifed lesions who underwent rotational atherectomy.
• Background: The characteristics and pattern of a CN and/or NC on clinical outcome remain unknown.
• Methods: Enrolled patients who underwent RA. IVUS imaging was mandatory. The primary outcome was
cumulative of DoCE, defined as the composite of cardiovascular death, myocardial infarction, and clinically-
driven target lesion revascularization
• Results:
• 200 patients enrolled. 5 Years follow up
• The cumulative DoCE was significantly higher in the CN/NC group than that in the non-CN/NC group (20.7%
vs. 8.8%, p = 0.022).
• MSA≤ 5.5 mm2 were correlated with a significantly higher cumulative DoCE
• CN/NC was the independent predictor for the cumulative DoCE (HR = 2.96, 95% CI 1.08–8.11, p = 0.035).
• Patients with an eccentric CN/NC had a significantly higher cumulative DoCE compared to those CN/NC with
concentric calcification.
• Conclusions: The presence of a CN/NC in patients with heavily calcified lesions who underwent RA-assisted
PCI was found to be associated with increased cumulative 5 year DoCE, especially in patients with an
33 eccentric CN/NC..
Clinical Outcomes RA in CN/NC cases IVUS F/u 5 years
• In contrast, the patient who had wire bias opposite to eccentric CN/NC had
increased 5 year DoCE.
• 60% of the patients with eccentric CN/NC and wire bias opposite to CN/NC
had increased 5 year DoCE.
• Conclusions : The presence of a calcified nodule or nodular calcification in
patients with heavily calcified lesions who underwent RA assisted PCI was
found to be associated with increased cumulative DoCE, especially in patients
with an eccentric calcified nodule or nodular calcification and wire bias
opposite to the calcified nodule
35
Orbital Atherectomy Major Trials/Registry
36
COAST & ORBIT-III
37
38 SPL XXXXXX Dispelling the Nodular Myths. Shockwave Medical 2023.
IVL Data
39
40
Dispelling the Nodular Myths
Myth:
Atherectomy Is the Ideal
Tool for Modifying Nodular
Calcium
Clinical Evidence:
IVL Can Safely and
Effectively Modify Nodular
Calcium
Post-IVL
Moderated Poster, TCT 121: Intravascular Lithotripsy is Effective in the Treatment Calcified Nodules: Patient-level Pooled Analysis From the Disrupt CAD OCT Sub-studies,
Ziad A. Ali, TCT 2021
Post-IVL Post-stent
Concentric Stent Expansion: Deformed Nodular Calcification
3 Common Patterns of Stent Expansion
Pre-IVL Post-IVL Post-Stent
Moderated Poster, TCT 121: Intravascular Lithotripsy is Effective in the Treatment Calcified Nodules: Patient-level Pooled Analysis From the Disrupt CAD OCT Sub-studies,
Ziad A. Ali, TCT 2021
Moderated Poster, TCT 121: Intravascular Lithotripsy is Effective in the Treatment Calcified Nodules: Patient-level Pooled Analysis From the Disrupt CAD OCT Sub-studies,
Ziad A. Ali, TCT 2021
Concentric expansion
Deformed eruptive calcified nodule
34% Eccentric
expansion
23%
Concentric expansion
Deformed nodular calcification
43% Concentric
expansion
77%
Eccentric expansion
Non-deformed nodular
calcification
23%
Concentric stent expansion in
majority of calcified nodular lesions
Target lesion stenosis ≥50% and <100% ≥50% and <100% ≥70% and <100% ≥70% and <100%
*Patient enrollment in OCT sub-studies was open to all sites participating in the Disrupt CAD studies that routinely perform OCT imaging. †Includes patients from the roll-in cohort.
10
%
6 6.5 6.3
6.1 6.0
4 50%
0 0%
MLA MSA Mean stent area Stent expansion @MCS Mean stent expansion
N, lesions 54 194 54 194 54 194 N, lesions 54 194 54 194
Moderated Poster, TCT 121: Intravascular Lithotripsy is Effective in the Treatment Calcified Nodules: Patient-level Pooled Analysis From the Disrupt CAD OCT Sub-studies,
Ziad A. Ali, TCT 2021
13.9%
10 8.0%
0
0 1 6 12 18 24
Months
In Conclusion: IVL in Calcific Nodules
Good Initial Insights But Still More to Learn
Consistent MSA With/Without Nodules IVL Safely Deforms Nodules Promising Longer-Term Outcomes
What’s Next: More data are needed on nodules in larger, “real-world” cohorts across all
calcium arcs, and the role of combination therapy (i.e. atherectomy + IVL) in order to
determine the optimal nodular strategy.